Baxter Healthcare Corporation recalls Ondansetron Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed pH Specifications
- Products
-
- Ondansetron Injection
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 6,022,675 vials
- About this recall
- Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25